Victrex plc (LON:VCT) insider Timothy (Tim) J. Cooper acquired 5 shares of the company’s stock in a transaction that occurred on Thursday, November 16th. The stock was purchased at an average cost of GBX 2,461 ($32.37) per share, for a total transaction of £123.05 ($161.84).
Victrex plc (VCT) opened at GBX 2,497 ($32.84) on Friday. Victrex plc has a 52 week low of GBX 1,684 ($22.15) and a 52 week high of GBX 2,537 ($33.37).
TRADEMARK VIOLATION WARNING: “Timothy (Tim) J. Cooper Acquires 5 Shares of Victrex plc (VCT) Stock” was published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://sportsperspectives.com/2017/11/19/timothy-tim-j-cooper-acquires-5-shares-of-victrex-plc-vct-stock.html.
A number of analysts recently weighed in on VCT shares. Liberum Capital reaffirmed a “buy” rating and issued a GBX 2,240 ($29.46) price objective on shares of Victrex plc in a report on Monday, September 4th. Peel Hunt reaffirmed an “add” rating and issued a GBX 2,100 ($27.62) price objective on shares of Victrex plc in a report on Tuesday, July 25th. J P Morgan Chase & Co increased their price objective on shares of Victrex plc from GBX 1,800 ($23.67) to GBX 2,150 ($28.28) and gave the stock a “neutral” rating in a report on Tuesday, September 5th. Berenberg Bank raised shares of Victrex plc to a “buy” rating and increased their price objective for the stock from GBX 2,000 ($26.31) to GBX 2,600 ($34.20) in a report on Wednesday, September 6th. Finally, UBS AG started coverage on shares of Victrex plc in a report on Monday, August 21st. They issued a “neutral” rating and a GBX 2,050 ($26.96) price objective on the stock. Eight investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Victrex plc has a consensus rating of “Hold” and a consensus price target of GBX 2,191.64 ($28.83).
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex plc and related companies with MarketBeat.com's FREE daily email newsletter.